Designing a Defensible Clinical Study with an AI Co-Pilot
AI can accelerate protocol work, but the burden of justification stays with the investigators. A model can enumerate options, expose missing fields, and challenge internal consistency. It cannot know whether a design is ethical, feasible at the site, or aligned with the clinical decision the study is meant to inform.
Why AI Speeds Up the Wrong Things
The default AI use in study design is generating an outline. That's the least valuable stage to outsource. The decisions that determine whether your study can actually answer the question happen in PICO framing, design selection, and randomization scheme. Rush those with AI and you get a well-formatted protocol with a fundamental flaw buried inside it.
The six stages below put AI where it earns its keep. Each names the prompt and the human check that can't be automated away.
Stage 1: PICO Sharpening
Feed the model your rough research question and ask it to enumerate every plausible PICO interpretation — population strata, outcome timing, comparator options, feasible follow-up durations. Don't ask it to pick one. Ask it to surface the decision space.
The human check: you select the PICO that matches your patient population, available data, and institutional capacity. The model expands the possibility space; you constrain it to what's real. This is the stage where clinical researchers are often too narrow too early — and where AI is genuinely useful as a structured prompt for scope.
Stage 2: Design Fit
Once PICO is fixed, prompt: “Given this PICO, list the study designs that could answer it, with the main assumption each design requires and the sample-size implications.” Treat the result as a comparison table, not a recommendation.
The human check: does the clinical context satisfy each design’s assumptions, and can the required data actually be collected? Missing parameter evidence should stay visible rather than being replaced with a convenient default.
For red-teaming the chosen design itself — finding the holes in your protocol before reviewers do — red-teaming study design with Claude covers that systematically.
Stage 3: Sample Size
Feed the model the design narrative — not the formula — and ask it to name the statistical test, enumerate the inputs required for a power calculation, and then calculate. The failure pattern: Claude defaults to simple parallel-arm formulas and routinely misses inflation factors for clustering, non-inferiority margins, and expected dropout.
The human check: confirm the test family matches your design before accepting any numbers. If you're running a cluster trial and Claude doesn't mention ICC inflation, the calculation is wrong. A 10-minute human check here is cheaper than an underpowered study.
Stage 4: Randomization
Generate randomization code with AI only after the allocation procedure is approved. Audit three things manually: allocation concealment, stratification or minimization variables, and the audit trail. Fixed, visible block sizes can make future assignments predictable even when the code itself is syntactically correct.
Read the generated code before running it. Every time.
Stage 5: Reporting Standard
Ask the model to propose the relevant reporting guideline for your design—such as CONSORT, STROBE, STARD, or PRISMA-DTA—then verify the choice on the guideline and journal websites. Fill out the checklist before writing begins. This exposes information the protocol still needs.
An LLM can map checklist items to protocol sections; it cannot certify methodological quality. The research workflow on choosing a study design goes deeper on design taxonomy if you need to revisit the classification before this step.
Stage 6: Pre-Registration
Draft the OSF preregistration with AI assistance, but protect the analysis plan. False precision records choices the team never made; vague language leaves too many undisclosed analytical branches.
Prompt: “Using only this approved protocol and analysis plan, draft the OSF fields. Cite the source of each analytical choice and mark missing decisions.” Resolve every marker before registering. The timing of preregistration should follow the applicable design and registry requirements.
What AI Commonly Gets Wrong
The biggest trap is not a dramatic hallucination. It is a plausible-looking default that slides in because the model is trying to be helpful. In study design, that usually means one of four things: the population is too broad, the comparator is too weak, the outcome is too vague, or the analysis plan assumes more precision than the data can support.
If the output names a test without the design context, or supplies a precise outcome definition absent from the protocol, treat that as an unresolved decision. Readability does not convert a default into evidence.
A Practical Prompt Stack
You do not need one giant prompt. You need a sequence that narrows the design step by step:
- "Here is the rough clinical question. Give me every plausible PICO version and tell me what would change for each."
- "Given these PICO options, list the study designs that could answer them and what assumption each one depends on."
- "For the selected design, list the minimum data elements, the primary outcome, likely confounders, and the first-pass sample size logic."
- "Generate a draft protocol skeleton, but flag any section where you are assuming missing information."
- "Create a checklist of human review points that must be signed off before registration."
That sequence keeps missing information visible before the prose becomes polished. Also ask for the next-best design or outcome definition and its tradeoff; comparison exposes assumptions that a single recommendation can hide.
When Not to Use AI
Institutional feasibility, ethics, data access, consent burden, and local workflow constraints require decisions from accountable people at the site. Use AI to structure the questions, never to approve a choice that changes participant risk or the validity of inference.
The Real Payoff
The payoff is an explicit decision trail: the model generates candidate structure, the clinician defines the constraints, and the statistician verifies the consequences. If the model sounds certain before the team has decided, stop. The useful output is the one that makes uncertainty visible early enough to resolve.
The Research Mentor tools at AI for Academic can help structure idea validation and PICO development. Use the output to open the design discussion; do not treat it as protocol approval.